[TVTX] QoQ Quarter Result on 30-Sep-2024 [#Q3]

Stock
[TVTX] Travere Therapeutics, Inc.
Announcement Date
31-Oct-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- 22.15%
YoY- -136.36%
Quarter Report
TVTX's Result
TVTX's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 62,898 54,116 41,374 45,059 37,095 59,697 56,993 6.77%
PBT -54,836 -69,567 -135,767 -88,528 -89,229 -85,565 -86,253 -26.00%
Tax -84 85 191 68 -12 65 78 -
NP -54,811 -70,409 -136,061 -90,173 150,735 -85,630 -86,331 -26.06%
Tax Rate - - - - - - - -
Total Cost 117,709 124,525 177,435 135,232 -113,640 145,327 143,324 -12.26%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin -87.14 -130.11 -328.86 -200.12 406.35 -143.44 -151.48 -30.76%
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS -0.70 -0.91 -1.76 -1.18 -0.99 -1.13 -1.27 -32.70%
EPS Diluted -0.70 -0.91 -1.76 -1.18 -0.99 -1.13 -1.27 -32.70%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.